Molecular Docking and Dynamic Simulation of AZD3293 and Solanezumab Effects Against BACE1 to Treat Alzheimer's Disease

The design of novel inhibitors to target BACE1 with reduced cytotoxicity effects is a promising approach to treat Alzheimer's disease (AD). Multiple clinical drugs and antibodies such as AZD3293 and Solanezumab are being tested to investigate their therapeutical potential against AD. The curren...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Mubashir Hassan, Saba Shahzadi, Sung Y. Seo, Hany Alashwal, Nazar Zaki, Ahmed A. Moustafa
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2018-06-01
Serie:Frontiers in Computational Neuroscience
Ämnen:
Alzheimer's disease
computational modeling
dynamic simulation
AZD3293
solanezumab
Länkar:https://www.frontiersin.org/article/10.3389/fncom.2018.00034/full
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk